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Abstract
Background: Although malaria rapid diagnostic tests (RDTs) have been extensively evaluated since their
introduction in the early 1990’s, sensitivity and specificity vary widely limiting successful integration into clinical
practice. This paper reviews specific issues surrounding RDT use in field settings and presents results of research
investigating how to interpret “faint test bands” on ParaCheck Pf
® in areas of low transmission in order to reduce
malaria misdiagnosis.
Methods: A multi-phase cross-sectional study was conducted at a remote hospital in the northern Tanzanian
highlands. Capillary blood samples were taken from consenting participants (n = 319) for blood smear and
ParaCheck Pf
® testing. Primary outcome variables were sensitivity, specificity and proportion misdiagnosed by
ParaCheck Pf
® and local microscopy. ParaCheck Pf
® “faint bands” were classified as both true positives or true
negatives during evaluation to determine appropriate clinical interpretation. Multivariate logistic regression adjusted
for age and gender was conducted to determine odds of misdiagnosis for local microscopy and ParaCheck Pf
®.
Results: Overall, 23.71% of all ParaCheck Pf
® tests resulted in a “faint band” and 94.20% corresponded with true
negatives. When ParaCheck Pf
® “faint bands” were classified as positive, specificity was 75.5% (95% CI = 70.3% -
80.6%) as compared to 98.9% (95% CI = 97.0% - 99.8%) when classified as negative. The odds of misdiagnosis by
local microscopy for those > 5 years as compared to those ≤ 5 years are 0.370 (95% CI = 0.1733 - 0.7915, p =
0.010). In contrast, even when ParaCheck Pf
® faint bands are considered positive, the odds of misdiagnosis by
ParaCheck Pf
® for those > 5 years as compared to those ≤ 5 years are 0.837 (95% CI = 0.459 - 1.547, p = 0.5383).
Conclusions: We provide compelling evidence that in areas of low transmission, “faint bands” should be
considered a negative test when used to inform clinical decision-making. Correct interpretation of RDT test bands
in a clinical setting plays a central role in successful malaria surveillance, appropriate patient management and
most importantly reducing misdiagnosis.
Background
Current recommendations of effective, yet expensive arte-
misinin-based combination therapies (ACT) for malaria in
S u b - S a h a r a nA f r i c ah a v ei n c r e a s e dt h ei m p o r t a n c eo f
laboratory-confirmed diagnosis [1-3]. The current diag-
nostic “gold standard” for malaria diagnosis is direct
microscopic visualization of parasites on thick and/or thin
blood smears [4,5]. Unfortunately, in many health facilities
in Sub-Saharan Africa there is a lack of properly function-
ing microscopes, quality control systems and well-trained
laboratory technicians [6]. Due in part to these limitations,
clinicians at health facilities may develop limited trust in
the accuracy of microscopy results and rely solely on clini-
cal judgment even when laboratory results are available
[7]. This is particularly troubling since the clinical symp-
toms of malaria are non-specific and overlap with a num-
ber of other tropical infectious diseases [8]. As a result,
clinically similar diseases may be treated as malaria, redu-
cing specificity, promoting over-use of anti-malarial drugs
and reducing the quality of care for patients [9].
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tial potential to help address these issues, especially in
resource poor areas [9]. In order for RDTs to be effective,
they must have high sensitivity for Plasmodium species
detection, paired with high specificity necessary to success-
fully reduce malaria associated morbidity and mortality
and accurately diagnose other tropical diseases [10]. This
successful combination will aid in the reduction of malaria
misdiagnosis, decrease treatment costs, reduce mispercep-
tions of therapeutic failures when fever is caused by other
diseases, and reduce selection pressure that leads to the
development of drug resistance [11].
H o w e v e r ,R D T sa r en o tap e r f e c ts o l u t i o na n dt h e r ei s
growing concern regarding their effectiveness, quality,
accuracy and perceived value. This paper reviews some
of the current literature on challenges associated with
RDTs and presents the results of research investigating
the interpretation of “faint bands” w h i c ha r eap r o b l e -
matic feature of some malaria RDTs [3,11,12].
Current Challenges with Malaria RDTs
Since the introduction of RDTs in the early 1990’s, there
have been over 100 published trial reports [13]. One of the
first and most extensively tested and utilized RDTs, Para-
Check Pf
® detects histidine rich protein 2 (HRP2) pro-
duced uniquely by Plasmodium falciparum [12,14-21].
Although the sensitivity of ParaCheck Pf
® is consistently
reported to be above 90% in hospital and field based stu-
dies, specificity varies from as low as 52% up to 99.5%
[11]. Variability in specificity may be associated with the
quality of the reference standard used, as studies rely on a
variety of tests (single or dual field microscopy, single or
dual hospital microscopy and polymerase chain reaction
(PCR)) [11]. Beyond this limitation, it has also been sug-
gested that ParaCheck Pf
® false positives can be attributed
to: reading the test after fifteen minutes, application of too
much blood, inappropriate dilution/concentration of buf-
fer, contamination of the sample, backflow of sample and
conjugate leading to entrapment at the detection line, high
titers of non-specific anti-bodies due to viral infection or
the presence of rheumatoid factor [2,6,14,22]. The appear-
ance of “faint test bands” on RDTs such as ParaCheck Pf
®
also may have implications for producing false positives
during practical interpretation.
In previous reports from a hyper-endemic area of
Uganda, Kyabayinze et al. (2008) identified “faint test
bands” in ParaCheck Pf
® (bands that can only be seen in
good light) and classified them true positives using con-
cordance values between two HRP2 RDTs [5]. Aside
from this study, the majority of previous research either
does not identify faint bands, or may have included them
as either true positives or negatives without further inves-
tigation. As malaria prevalence continues to fall due to
successful preventative measures, and if RDTs are truly
the answer to improve the accuracy of malaria diagnosis,
it is imperative to have clear guidelines for interpretation
of ParaCheck Pf
® results in various malaria transmission
settings.
In this paper, we evaluate the sensitivity and specificity
of ParaCheck Pf
® against microscopy in an area of low
malaria transmission in the Tanzanian highlands and
determine whether, in this setting “faint bands” are most
frequently associated with true positives or negatives. In
addition, we provide a comparison of malaria misdiagnosis
based on local microscopy as compared to ParaCheck Pf
®
and use these findings to propose potential implications
for areas of low malaria transmission.
Methods
Study site
This study was conducted at a rural hospital in the Ngor-
ongoro Conservation Area (NCA) located within the high-
lands of northern Tanzania where the temperature can
range from 2°C to 35°C annually. The hospital laboratory
relies on generator power for electricity and sunlight
through open windows is the major source of lighting.
Altitude in the NCA ranges from 1000 m to over 3000 m
placing the majority of the population in a low transmis-
sion zone for malaria. Based on hospital outpatient
records, the reported prevalence of malaria at the hospital
was over 40%, but it is anticipated that the actual preva-
lence of malaria in the NCA is estimated to be 9.3% [7].
Interpretation of these statistics indicates that over-diag-
nosis of malaria may be of concern in this area.
Study design
A multi-phase cross-sectional study was conducted to
determine accuracy of ParaCheck Pf
® as compared to
local hospital microscopy and external quality control
(QC) performed at the Bugando University College of
Health Sciences (BUCHS) in Mwanza, Tanzania. Study
design was based on the World Health Organization
(WHO) Evaluation of diagnostic tests for infectious dis-
eases: general principles [23] and the WHO Evaluation of
rapid diagnostic tests: malaria [24]. A demographic and
health seeking behavior questionnaire was administered in
parallel to participants in all study groups in order to
determine if individual-specific factors are associated with
ParaCheck Pf
® sensitivity, specificity and the appearance
of faint bands (see Appendix A for questionnaire).
Sample size calculation
Sample size was calculated using 95% confidence, an
expected malaria prevalence of 9.3% [7] and precision
level of 5%. The simple formula of n = Z
2 P(1-P)/d
2,
where n = sample size, Z = Z statistic for a level of confi-
dence, P = expected prevalence or proportion and d =
precision was used for calculations [25]. The resulting
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was doubled in order for the age groups to be dichoto-
mized during logistic regression analysis resulting in a
final total sample size of n = 258.
Participants
Inclusion criteria
patients presenting with clinical features of malaria sent
for microscopy investigations after giving informed
consent.
Exclusion criteria
any women with known or suspected pregnancy, patients
with severe and/or complicated malaria, and patients
with severe and complicated co-morbidities as defined by
the clinical health officers. Patients were excluded if they
had received anti-malarial therapy at the hospital in the
last 2 weeks.
Sampling strategy
Using convenience sampling [26], research personnel
identified all potential participants presenting to the out-
patient department of the hospital within the data collec-
tion time frame (January, May and June of 2009).
Although a random sample of potential participants
would be ideal, it has limited feasibility as an average of
10 - 15 patients/day present with malaria-like symptoms
at the study site.
Patient Demographics and Health Seeking Behaviors
Following provision of informed consent, patient demo-
graphics (age, gender, Maasai age class and previous
cases of malaria) and health seeking behaviors (days wait-
ing before presenting to hospital and time traveled) were
recorded using a previously pilot tested and validated
questionnaire (additional file 1). This enabled the
researchers to investigate associations with positive,




In the laboratory, blood was obtained by a finger prick and
a thick and thin blood smear were prepared according to
standard WHO procedures [27]. One of the laboratory
technicians working in the hospital laboratory stained
slides with either Fields stain or Giemsa and estimated
parasite density against 200 white blood cells. At least 100
fields on each slide were examined before the slide could
be declared negative for malaria parasites [27]. Local hos-
pital microscopists were blinded to the results of Para-
Check Pf
® and to the clinical outcome [24]. Blood slides
were stored in a cool and dark location until being sent to
BUCHS to be read by 2 independent expert parasitologists.
QC parasitologists were blinded to each other as well as
the local hospital microscopy results and the ParaCheck
Pf
® results.
All microscopists both at the rural hospital in the
Ngorongoro and BUCHS hold a three-year diploma in
laboratory techniques with more than six years working
experience in the laboratory (parasitology section). In
addition they all have been attending refresher courses
to improve their skills in malaria microscopy. At both
sites, the WHO standard operating procedures for




® (Orchid Biomedical Systems, Verna Goa,
India) was used for the qualitative detection of Plasmo-
dium falciparum. The tests were stored in a cool and dry
location for the duration of the trial until use, and each
package was examined for the integrity of the desiccant.
Standard protocol was followed by trained research per-
sonnel, where 5 μl of fresh capillary blood was transferred
using the provided loop applicator to the test window
and then 6 drops of sample buffer were added to the buf-
fer well. Once a ParaCheck Pf
® package was opened, it
was used immediately. Trained research staff interpreted
RDT results for exactly 15 minutes following the addition
of the buffer solution as recommended by the manufac-
turer. In all cases, interpretation of ParaCheck Pf
® results
was overseen and confirmed by the lead author. In order
to ensure integrity of interpretation, all research person-
nel involved in ParaCheck Pf
® interpretation were
blinded to both the results of microscopy as well as the
clinical decision.
The presence of a band in both the control and test line
indicates a positive test for P. falciparum. A negative result
was indicated by the presence of a control band and the
absence of a test band. A “faint band” was identified using
the same definition as Kyabayinze et al. (2008), where
“faint bands” are those that are only visible in good light.
Good light is defined as viewing the ParaCheck Pf
® test in
direct sunlight (all tests were conducted between 9 am
and 4 pm). A test was considered invalid when the control
line did not appear or the test failed to clear remaining
blood from the test area. The final diagnosis and further




After completion of standard WHO microscopy proce-
dures [27], a blood smear was considered to be either a
true positive or true negative only when both external
QC readers agreed on the result. Percent agreement and
kappa values were used for analysis [28]. Parasitemia
level was not considered for true positives, only that both
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w a su s e da sam e a s u r eo fi n f e c t i o ns e v e r i t yf o rc l i n i c a l




Timers were used to ensure that tests were read at exactly
15 minutes. In the case of a “faint band” a second observer
was consulted to determine the presence of a “true faint
band”. “Faint bands” were considered present only if both
observers agreed.
Ethical considerations
Ethical approval from the Conjoint Health Ethics Board
(CHREB) at the University of Calgary and the National
Institute of Medical Research (NIMR) in Tanzania as
well as a research permit required in Tanzania from the
Commission on Science and Technology (COSTECH)
were received.
Data analysis
All data were entered into Microsoft Excel and checked by
a second researcher for consistency against original data
sources, then analysis was done using STATA version
11.0. The variable misdiagnosis was created for both local
microscopy and ParaCheck Pf
® by coding the test result as
a misdiagnosis when there was a disagreement with the
external QC result and the test result (i.e. ParaCheck Pf
®
w a sp o s i t i v ea n dt h eQ Cr e s u l tw a sn e g a t i v e ,o rv i c e
versa). Logistic regression adjusting for age and gender
was conducted to determine the odds of misdiagnosis
using ParaCheck Pf
® or local microscopy. All confidence
intervals are calculated using the Exact-Method.
Results
Malaria Prevalence
For prevalence calculations, the population is defined as
patients who are suspected of malaria by a clinical officer
or physician at the outpatient department of the local
rural hospital. The resulting prevalence estimates are
shown in Table 1.
Study Participants
A total of 319 study participants were divided into three
study groups: 1) malaria-like symptoms ≤5 years (n = 98),
2) malaria-like symptoms > 5 years (n = 122) and 3) a
control group presenting with non-malaria-like symp-
toms > 5 years (n = 71). Due to inconsistencies and miss-
ing data, the sample size used for analysis was n = 291.
Of the 291 participants, there were approximately equal
numbers of males and females (females n = 147), a larger
proportion of patients were > 5 years (n = 193), waited
longer than 1 day to present at the hospital (n = 225) and
a small proportion had to travel longer than 3 hours to
get to the hospital (n = 40).
Quality Control
The external QC readers were regarded as the gold
standard for this evaluation. Evaluation of external QC
reader inter-rater reliability resulted in 97.25% agree-
ment (kappa = 0.5859, SE = 0.0583, p < 0.0001). There
were 8 cases out of 291 that the QC readers did not
agree. These cases were then excluded from calculations
that use true positives or true negatives. The proportion
of true positives determined by agreement between both
external QC readers was 2.10% (6/283).
ParaCheck Pf
®
Overall, 23.71% of all ParaCheck Pf
® tests resulted in a
“faint band” (Table 2). When adjusted for age and gender,
the odds of a ParaCheck Pf
® “faint band” test result for
those > 5 years as compared to those ≤ 5y e a r sw a s0 . 8 6 2
(95% CI = 0.474-1.591, p = 0.607). Only 4.34% (3/69) of
“faint bands” corresponded with a true positive, and
94.20% (65/69) of “faint bands” corresponded with true
negatives (Table 2). The remaining 1.46% (1/69) of “faint
Table 1 The estimated prevalence of malaria in patients
who are suspected of malaria by a clinical officer or
physician at the out-patient department of the local rural
hospital using local microscopy, ParaCheck Pf
® and
quality control microscopy
Diagnostic Method Estimated Prevalence
Local Microscopy 46.4% (95% CI = 40.6%-52.2%)
ParaCheck Pf
®
(If classify faint bands as -)
1.7% (95% CI = 0.2%-3.2%)
ParaCheck Pf
®
(If classify faint bands as +)
25.4% (95% CI = 20.4%-30.5%)
Quality Control Microscopy 2.1% (95% CI = 0.4%-3.8%)
Table 2 The proportion of faint band appearance,
ParaCheck Pf
® misdiagnosis with either positive or
negative “faint band” classification, local microscopy
misdiagnosis and true positives
ParaCheck
® faint bands and misdiagnosis Proportion
ParaCheck Pf
® tests resulting in a faint band (n = 291) 69 (23.7%)
ParaCheck Pf
® positive (if classify faint as +) (n = 291) 74 (25.4%)
ParaCheck Pf
® positive (if classify faint as -) (n = 291) 5 (1.7%)
ParaCheck Pf
® Misdiagnosis (if classify faint as +) (n = 283) 68 (23.4%)
ParaCheck Pf
® Misdiagnosis (if classify faint as -)
(n = 283)
1 (0.35%)
Misdiagnosis with local microscopy (n = 283) 131 (45.0%)
True positives determined by external QC (n = 283) 6 (2.1%)
ParaCheck Pf
® faint Bands corresponding with true
positives* (n = 69)
3 (4.3%)
ParaCheck Pf
® faint Bands corresponding with true
negatives* (n = 69)
65 (94.2%)
*True positives and true negatives were determined by external quality
control
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results between QC readers and therefore it was
excluded. When ParaCheck Pf
® bands were classified as
positive the inter-rater agreement with the gold standard
of external QC was 75.62% (kappa = 0.091, SE = 0.0279,
p = 0.0006). In contrast, when ParaCheck Pf
® test bands
were classified as negative the inter-rater agreement with
the QC gold standard was 97.53% (kappa = 0.3511, SE =
0.0592, p < 0.001).
Malaria Misdiagnosis
Misdiagnosis of malaria is defined as any outcome where
the local hospital microscopy or ParaCheck Pf
® test
result did not agree with microscopy QC results. When
“faint bands” were classified as positive tests, the propor-
tion of ParaCheck Pf
® misdiagnosis was 23.4% (95% CI =
18.5%-28.3%)(Table 2). If “faint bands” were classified as
negative, misdiagnosis by ParaCheck Pf
® decreased to
only 0.353% (95% CI = -0.33%-1.0%) (Table 2). These
misdiagnosis proportions are in contrast to the 45.0%
(95% CI = 39.3%-50.8%) of patients that were misdiag-
nosed using local microscopy alone. Results from multi-
variate logistic regression indicate that the odds of
misdiagnosis by local microscopy for those > 5 years as
compared to those ≤ 5 years were 0.370 (95% CI =
0.1733-0.7915, p = 0.010). In contrast, even when Para-
Check Pf
® faint bands are considered positive, the odds
of misdiagnosis by ParaCheck Pf
® for those > 5 years as






® “faint bands” were classified as true
positives, specificity was 75.5% (95% CI = 70.3%-80.6%)
as compared to 98.9% (95% CI = 97.0%-99.8%) when
“faint bands” were classified as negative. For blood slide
parasitemia results > 600 parasites/μL( a s s u m i n g8 , 0 0 0
leukocytes/μL) the sensitivity was 100% for both the
“faint band” negative and positive classifications. When
the “faint bands” were classified as negative, 3 out of 69
patients with parasitemia values ≤ 600 parasites/μLw e r e
not detected and became false negatives.
Microscopy
The sensitivity of blood smears performed by the local
hospital was 83.3% (95% CI = 35.9%-99.6%) and specifi-
city was 54.4% (95% CI = 48.4%-60.3%). All values were
calculated using the external QC microscopy as the “gold
standard”.
Discussion
Prior to the start of our research, the local hospital
records estimated the prevalence of malaria in patients
presenting with malaria-like symptoms at the out-patient
department to be 46% in 2008 [29]. This is significantly
higher than the expected prevalence in a low transmis-
sion zone. The unusually high reported prevalence
sparked our interest into the accuracy of local micro-
scopy and the potential usefulness of RDTs in this area.
During this study we confirmed that the actual preva-
lence of malaria is much lower than previously reported
and were able to begin to provide a correction in the
understanding of local epidemiology at the hospital.
Further, in this study correct interpretation of Para-
Check Pf “faint bands” as negative was found to be asso-
ciated with a decrease in misdiagnosis (especially for
children under five years) as compared to local micro-
scopy. These results may indicate that the use of RDTs
will provide an objective parasitological tool to accurately
diagnose malaria in children and adults. As the current
WHO Guidelines for malaria diagnosis and treatment
still promote presumptive diagnosis of malaria for chil-
dren < 5 years in areas where parasite-based diagnosis is
not available, RDTs may have important implications for
reducing over-diagnosis in resource poor areas [30].
Moreover, the objectivity of RDTs may have important
implications for: quality of patient care, reducing unne-
cessary treatment costs, correcting misperceptions of
therapeutic failures and ultimately reducing the likeli-
hood of ACT drug resistance in Plasmodium falciparum
[11,31].
Impact of incorrectly interpreting “faint bands”
In the current clinical environment where training and
experience results in presumptive malaria treatment and
belief that “a negative blood slide does not rule out
malaria” it is essential for training algorithms to clarify
how to interpret “faint bands” occurring in ParaCheck
Pf
® and potentially other RDTs should be interpreted [3].
Here, we provide compelling evidence that in areas of
low transmission, “faint bands” should be considered a
negative test when used to inform clinical decision-mak-
ing. Although this may be at odds with current WHO
recommendations (http://www.wpro.who.int/sites/rdt),
we assert that this is an important consideration in areas
of low transmission.
In this setting, if faint bands are interpreted as true posi-
tives and the patient is treated with anti-malarial drugs,
this may result in the wrong disease being treated and
augment morbidity and unnecessary drug expenses. At the
health system level, incorrect interpretation may lead to
decreased trust of RDTs, create perceptions of treatment
failures and result in an over-estimation of the prevalence
of malaria in the area. The consequences are a reinforce-
ment of the culture of presumptive treatment and inaccu-
rate treatment of patients. Especially for areas of low
transmission, it is vital to have an accurate prevalence esti-
mate in order to track epidemiological trends and the
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climate change.
Possible reasons for “faint bands”
Although we have not conducted targeted studies to deter-
mine the precise underlying reason that “faint bands”
appear we propose the following hypothesis based on pre-
vious explanations of false positives. ParaCheck Pf
® uses a
loop applicator with the interior of the loop applicator
being calibrated for 5 μl. In field settings the method of
blood application is usually dropping the blood onto the
loop, leading to the formation of a bubble above the loop
structure. The result is the addition of greater than 5 μlt o
the test strip. Application of too much blood has been
identified previously as a contributing factor to false posi-
tive results, although the authors did not discuss band
intensity [6]. Further, the HRP2 antigen, detected by the
ParaCheck Pf
® RDT, has been previously shown to remain
in the bloodstream up to 60 days following anti-malaria
treatment leading to false positive test results [30]. Future
research should focus on determining a definitive under-
standing of what causes “faint bands” in various contexts.
Potential limitations
It may be possible that “faint bands” are due to low-level
parasitemias that are commonly found in areas of low pre-
valence and often not detectable by microscopy, [1,10],
but we anticipate that the examination of blood smears by
two highly trained technicians helped to mitigate this risk.
For future studies, the gold standard would be to confirm
all microscopy results using polymerase chain reaction
(PCR). There is also the possibility that patients had HRP-
2 remaining in the blood following treatment of a previous
case of malaria [2]. We attempted to mitigate this issue by
asking patients to disclose previous cases of malaria in the
questionnaire and reviewing patient files for recorded pre-
vious cases.
Furthermore, it is important to remember that Para-
Check Pf
® categorized three patients with parasitemias <
600 parasites/μLa sf a l s en e g a t i v e sw h e n“faint bands” were
considered negative. The failure to treat these true positive
cases will have important ramifications for the individual
patient and their families (for example delayed treatment
may lead to the development of serious disease and ulti-
mately death of the patient). The risks associated with both
over and under treatment of malaria are serious and have
been previously discussed [32-34]. So, there remains the
critical factor of clinical judgment in the decision to treat
or not to treat when the result is a “faint band”.
Conclusions
This research shows that in an area of low malaria
transmission, over 94% of “faint bands” are associated
with negative microscopy results. Additionally, Para-
Check Pf
®, when interpreted correctly is a useful tool
for accurately estimating prevalence in a defined popula-
tion and reducing misdiagnosis of children under the
age of five in a low transmission setting. Discerning how
to interpret “faint bands” and the resulting impacts on
malaria misdiagnosis in areas of medium to high trans-
mission and may give different results and therefore we
advocate for further research that will add to the grow-
ing body of knowledge regarding RDTs and their inher-
ent strengths and limitations.
Additional material
Additional file 1: Questionnaire: Malaria and Rapid Diagnostic Tests.
This questionnaire was designed to support the testing of the ParaCheck
Pf
®® through collection of demographic information on study
participants as well as investigating their reported malaria health-seeking
behaviors. In collaboration with our research personnel, a clinical officer
or physician at the local hospital administered either in KiSwahili or Maa
the questionnaire to consenting participants. The questionnaire was pilot
tested for validity and reliability. During translation the questions were
translated into KiSwahili by author MM and then back translated into
English by another local research assistant.
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